Anti-Apoptin 抗体
Anti-Apoptin antibody
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Polyclonal Apoptin antibody. Suitable for WB, ELISA and reacts with Chicken anemia virus samples. Cited in 3 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Chicken anemia virus Cuxhaven-1/Germany VP3.
別名を表示する
Apoptin, VP3
- WB
Supplier Data
Western blot - Anti-Apoptin antibody (AB193612)
All lanes:
Western blot - Anti-Apoptin antibody (ab193612) at 2 µg/mL
All lanes:
Chicken anemia virus apoptin at 0.4 µg
Secondary
All lanes:
Polyclonal goat anti-rabbit at 1/10000 dilution
Predicted band size: 13 kDa,41 kDa
Observed band size: 40 kDa,41 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Without the addition of other interacting proteins Apoptin initiates programmed cell death specifically in cancerous or transformed cells. It functions as a monomer and does not require a complex to exert its apoptotic effects. Its specificity offers a promising cancer therapeutic strategy as it discriminates between cancerous and non-cancerous cells leading to selective cytotoxicity.
Pathways
Multiple studies indicate that Apoptin triggers apoptosis through pathways distinct from the typical p53-dependent mechanisms. It activates processes related to the intrinsic apoptotic pathway bypassing p53 which makes it valuable in targeting p53-deficient tumors. Additionally Apoptin interacts with proteins related to the apoptotic pathway including Bcl-2 homology 3 (BH3) enhancing mitochondrial membrane permeability.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (3)
Recent publications for all applications. Explore the full list and refine your search
Investigational new drugs 39:949-960 PubMed33534026
2021
Applications
Unspecified application
Species
Unspecified reactive species
Technology in cancer research & treatment 18:1533033819875166 PubMed31769345
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 13:579-586 PubMed28356932
2017
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com